Risk factors for neutropenic fever in lymphoma patients receiving chemotherapy

被引：0
|
作者：
Teegala, S. R. [1 ]
Zhou, X. [1 ]
Huen, A. [1 ]
Ji, Y. [1 ]
Fayad, L. E. [1 ]
Romaguera, J. E. [1 ]
Vadhan-Raj, S. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2007年 / 25卷 / 18期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
19616
引用
收藏
页数：1
相关论文
共 50 条
  • [31] Incidence and Risk Factors of Neutropenic Enterocolitis after Myelosuppressive Chemotherapy
    Seydoux, C.
    Brunel, A-S.
    Ahlyege, S.
    Cairoli, A.
    Spertini, O.
    Marchetti, O.
    Gavillet, M.
    Bochud, P. -Y.
    SWISS MEDICAL WEEKLY, 2022, 152 : 39S - 39S
  • [32] Neutropenic Fever-Associated Admissions Among Patients With Solid Tumors Receiving Chemotherapy During the COVID-19 Pandemic
    Baus, Courtney J.
    Kelley, Broc
    Dow-Hillgartner, Elizabeth
    Kyriakopoulos, Christos E.
    Schulz, Lucas T.
    Lepak, Alexander J.
    LoConte, Noelle K.
    JAMA NETWORK OPEN, 2023, 6 (03) : e234881
  • [33] Aztreonam plus piperacillin - empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy
    Fishman, A
    Chowers, M
    Altaras, M
    Beyth, Y
    Lang, R
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 1998, 19 (02) : 126 - 129
  • [34] Risk of chemotherapy-induced neutropenic complications when treating patients with non-Hodgkin lymphoma
    Lyman, Gary H.
    Poniewierski, Marek S.
    Culakova, Eva
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (04) : 483 - 492
  • [35] Clinical Highlights: Neutropenic Fever Following Chemotherapy
    不详
    ONCOLOGY NURSING FORUM, 2008, 35 (06) : 887 - 887
  • [36] Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
    Weycker, Derek
    Barron, Rich
    Edelsberg, John
    Kartashov, Alex
    Legg, Jason
    Glass, Andrew G.
    BMC HEALTH SERVICES RESEARCH, 2014, 14
  • [37] Risk and consequences of chemotherapy-induced neutropenic complications in patients receiving daily filgrastim: the importance of duration of prophylaxis
    Derek Weycker
    Rich Barron
    John Edelsberg
    Alex Kartashov
    Jason Legg
    Andrew G Glass
    BMC Health Services Research, 14
  • [38] Neoplasia patients with low-risk neutropenic fever related to chemotherapy as potential beneficiaries of home care programs
    Hernández, TI
    Lapeña, CS
    Gómez-Lus, R
    Martín, MG
    REVISTA CLINICA ESPANOLA, 2001, 201 (03): : 165 - 166
  • [39] The risk and microbiology of bacteremia in hemato-oncology patients with chemotherapy induced neutropenic fever and the need for antimicrobial prophylaxis
    Luedi, Miriam
    Pabst, Thomas
    Taeuber, Martin G.
    Fey, Martin F.
    Muehlemann, Kathrin
    SWISS MEDICAL WEEKLY, 2007, 137 : 61S - 61S
  • [40] Risk factors for chemotherapy-induced nausea in pediatric patients receiving highly emetogenic chemotherapy
    Dupuis, L. Lee
    Tamura, Roy N.
    Kelly, Kara M.
    Krischer, Jeffrey P.
    Langevin, Anne-Marie
    Chen, Lu
    Kolb, E. Anders
    Ullrich, Nicole J.
    Sahler, Olle Jane Z.
    Hendershot, Eleanor
    Stratton, Ann
    Sung, Lillian
    McLean, Thomas W.
    PEDIATRIC BLOOD & CANCER, 2019, 66 (04)
12345